Democrats Push to Halt Medicare AI Pilot Program Amid Concerns Over Patient Access

Senate and House Democrats have introduced resolutions to block a Medicare pilot program that uses artificial intelligence (AI) to approve or deny care, citing concerns over delayed treatment for seniors. The initiative, known as the Wasteful and Inappropriate Service Reduction (WISeR) program, has sparked bipartisan scrutiny after reports of care delays in at least one state and allegations of profit-driven denials.

GAO Ruling Forces Legislative Action

The latest legislative effort follows a recent Government Accountability Office (GAO) ruling that the WISeR program requires congressional approval. According to the GAO, the initiative—launched in January 2026—should have been submitted to Congress before implementation, as it falls under the scope of the Congressional Review Act (CRA). This legal requirement has now opened a pathway for lawmakers to challenge the program.

“Americans are sick and tired of abusive prior authorization tactics putting needed health care out of reach,” said Senator Ron Wyden (D-Ore.), a key sponsor of the resolution. “The last thing seniors need is even more AI denying the care they need.”

Concerns Over AI-Driven Care Denials

The WISeR program targets specific medical supplies and procedures deemed high-risk for fraud, excluding inpatient services, emergency care, and treatments with significant risks if delayed. However, critics argue the AI system is being used as a “denial device,” with providers reporting delays and denials of necessary care.

Senator Patty Murray (D-Wash.) and Representative Suzan DelBene (D-Wash.) highlighted the program’s flawed design, noting that it replicates the prior authorization practices of Medicare Advantage plans in traditional Medicare. “This program implements the same flawed prior authorization scheme from Medicare Advantage into traditional Medicare,” DelBene said. “If scaled up, it would be a back door to privatizing Medicare.”

Earlier this year, Senator Maria Cantwell (D-Wash.) testified before Congress that Washington state hospitals were experiencing care delays due to WISeR. She described the AI system as a tool for “denying care to Medicare patients so companies can profit.”

Payment Incentives and Contractor Accountability

A central controversy surrounds the payment structure for WISeR contractors, who are compensated based on an undisclosed formula that includes the number of procedures they deny. This has raised concerns that the model incentivizes rejecting care rather than approving it. In response, CMS Administrator Dr. Mehmet Oz pledged to audit contractors and terminate those with high inaccuracy rates.

“CMS will continue to review the opinion and assess any appropriate next steps consistent with applicable law and administrative processes,” a CMS spokesperson said after the GAO ruling. However, advocates argue that the program’s design fundamentally undermines patient access.

Legislative Pathways and Broader Implications

The resolution to invoke the CRA requires 30 Senate signatures to move to the floor, where it would face a simple majority vote. While the effort has drawn support from 20 Democratic senators, bipartisan backing remains uncertain. If passed, the WISeR pilot would be immediately halted.

The CRA has historically been used sparingly to overturn federal agency rules, with only 16 rules from the Obama administration successfully blocked during the Trump era. Still, the current push reflects growing unease over AI’s role in healthcare decision-making.

What This Means for Medicare Patients

The debate over WISeR underscores broader tensions between technological efficiency and patient safety. While AI has the potential to streamline care, its application in Medicare raises questions about transparency, accountability, and equitable access. For seniors, the stakes are high: delays in treatment can worsen health outcomes, particularly for conditions requiring timely intervention.

As the legislative battle unfolds, the outcome could set a precedent for how AI is regulated in public healthcare systems. For now, advocates are urging Congress to prioritize patient welfare over cost-saving measures that may compromise care.

Key Takeaways

• Democrats introduced resolutions to block the Medicare AI pilot program (WISeR) over concerns about delayed care and profit-driven denials.
• A GAO ruling confirmed the program requires congressional approval under the Congressional Review Act, enabling legislative action.
• WISeR uses AI to approve or deny specific medical services, but critics argue it incentivizes denying care through its payment structure.
• Congressional support for the resolution remains uncertain, but passage could halt the pilot and reshape AI’s role in Medicare.

For more information on the WISeR program, visit the GAO report or the Centers for Medicare and Medicaid Services.